PROEHL GERALD T - 16 Aug 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
President, CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Gerald T. Proehl
Issuer symbol
DRMA
Transactions as of
16 Aug 2021
Net transactions value
+$49,631
Form type
4
Filing time
17 Aug 2021, 12:38:51 UTC
Previous filing
12 Aug 2021
Next filing
26 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock Purchase $49,631 +10,000 $4.96 10,000 16 Aug 2021 By Proehl Family Trust F1, F8
transaction DRMA Common Stock Conversion of derivative security +17,857 17,857 17 Aug 2021 By Allison Taylor Proehl 2020 Irrevocable Trust F2, F8
transaction DRMA Common Stock Conversion of derivative security +8,928 8,928 17 Aug 2021 By Meghan Proehl Wilder 2020 Irrevocable Trust F2, F8
transaction DRMA Common Stock Conversion of derivative security +35,767 35,767 17 Aug 2021 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 F2, F8
transaction DRMA Common Stock Conversion of derivative security +361,147 +39% 1,278,464 17 Aug 2021 By Proehl Investment Ventures LLC F2, F8
transaction DRMA Common Stock Conversion of derivative security +111,951 +8.8% 1,390,415 17 Aug 2021 By Proehl Investment Ventures LLC F3, F8
transaction DRMA Common Stock Conversion of derivative security +181,585 +13% 1,572,000 17 Aug 2021 By Proehl Investment Ventures LLC F4, F8
transaction DRMA Common Stock Conversion of derivative security +1,247,904 +79% 2,819,904 17 Aug 2021 By Proehl Investment Ventures LLC F5, F8
transaction DRMA Common Stock Conversion of derivative security +85,640 +3% 2,905,544 17 Aug 2021 By Proehl Investment Ventures LLC F6, F8
transaction DRMA Common Stock Purchase +142,857 +1429% 152,857 17 Aug 2021 By Proehl Family Trust F8, F9
holding DRMA Common Stock 39,512 16 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -120,481 -100% $0.000000* 0 17 Aug 2021 Common Stock 17,857 By Allison Taylor Proehl 2020 Irrevocable Trust F2, F8
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -60,240 -100% $0.000000* 0 17 Aug 2021 Common Stock 8,928 By Meghan Proehl Wilder 2020 Irrevocable Trust F2, F8
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -241,325 -100% $0.000000* 0 17 Aug 2021 Common Stock 35,767 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 F2, F8
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -2,436,657 -100% $0.000000* 0 17 Aug 2021 Common Stock 361,147 By Proehl Investment Ventures LLC F2, F8
transaction DRMA Series 1a Preferred Stock Conversion of derivative security $0 -2,295,000 -100% $0.000000* 0 17 Aug 2021 Common Stock 111,951 By Proehl Investment Ventures LLC F3, F8
transaction DRMA Series 1b Preferred Stock Conversion of derivative security $0 -3,722,500 -100% $0.000000* 0 17 Aug 2021 Common Stock 181,585 By Proehl Investment Ventures LLC F4, F8
transaction DRMA Series 1c Preferred Stock Conversion of derivative security $0 -25,582,050 -100% $0.000000* 0 17 Aug 2021 Common Stock 1,247,904 By Proehl Investment Ventures LLC F5, F8
transaction DRMA Series 1 Preferred Stock Conversion of derivative security $0 -1,755,622 -100% $0.000000* 0 17 Aug 2021 Common Stock 85,640 By Proehl Investment Ventures LLC F6, F8
transaction DRMA Series 1a Warrants Conversion of derivative security $0 -573,750 -100% $0.000000* 0 17 Aug 2021 Common Stock 27,987 By Proehl Investment Ventures LLC F7, F8
transaction DRMA Warrant to Purchase Common Stock Conversion of derivative security $0 +27,987 $0.000000 27,987 17 Aug 2021 Common Stock 27,987 $20.50 By Proehl Investment Ventures LLC F8
transaction DRMA Warrant to Purchase Common Stock Purchase +142,857 142,857 17 Aug 2021 Common Stock 142,857 $7.00 By Proehl Family Trust F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.84 to $5.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2 The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
F3 The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
F4 The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
F5 The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
F6 The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
F7 The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.
F8 Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F9 Reporting Person purchased 142,857 Units in the IPO at $7.00 per Unit Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock.